342 related articles for article (PubMed ID: 20531961)
1. ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile.
Nalca A; Zumbrun EE
Drug Des Devel Ther; 2010 May; 4():71-9. PubMed ID: 20531961
[TBL] [Abstract][Full Text] [Related]
2. Human antibody responses to the polyclonal Dryvax vaccine for smallpox prevention can be distinguished from responses to the monoclonal replacement vaccine ACAM2000.
Pugh C; Keasey S; Korman L; Pittman PR; Ulrich RG
Clin Vaccine Immunol; 2014 Jun; 21(6):877-85. PubMed ID: 24759651
[TBL] [Abstract][Full Text] [Related]
3. ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine.
Greenberg RN; Kennedy JS
Expert Opin Investig Drugs; 2008 Apr; 17(4):555-64. PubMed ID: 18363519
[TBL] [Abstract][Full Text] [Related]
4. The new ACAM2000 vaccine and other therapies to control orthopoxvirus outbreaks and bioterror attacks.
Handley L; Buller RM; Frey SE; Bellone C; Parker S
Expert Rev Vaccines; 2009 Jul; 8(7):841-50. PubMed ID: 19538111
[TBL] [Abstract][Full Text] [Related]
5. Unintentional transfer of vaccinia virus associated with smallpox vaccines: ACAM2000(®) compared with Dryvax(®).
Tack DM; Karem KL; Montgomery JR; Collins L; Bryant-Genevier MG; Tiernan R; Cano M; Lewis P; Engler RJ; Damon IK; Reynolds MG
Hum Vaccin Immunother; 2013 Jul; 9(7):1489-96. PubMed ID: 23571177
[TBL] [Abstract][Full Text] [Related]
6. A novel, cell culture-derived smallpox vaccine in vaccinia-naive adults.
Artenstein AW; Johnson C; Marbury TC; Morrison D; Blum PS; Kemp T; Nichols R; Balser JP; Currie M; Monath TP
Vaccine; 2005 May; 23(25):3301-9. PubMed ID: 15837236
[TBL] [Abstract][Full Text] [Related]
7. Interferon α/β Decoy Receptor Encoded by a Variant in the Dryvax Smallpox Vaccine Contributes to Virulence and Correlates with Severe Vaccine Side Effects.
Liu R; Americo JL; Earl PL; Villani J; Cotter CA; Moss B
mBio; 2022 Feb; 13(1):e0010222. PubMed ID: 35189701
[TBL] [Abstract][Full Text] [Related]
8. Genomic differences of Vaccinia virus clones from Dryvax smallpox vaccine: the Dryvax-like ACAM2000 and the mouse neurovirulent Clone-3.
Osborne JD; Da Silva M; Frace AM; Sammons SA; Olsen-Rasmussen M; Upton C; Buller RM; Chen N; Feng Z; Roper RL; Liu J; Pougatcheva S; Chen W; Wohlhueter RM; Esposito JJ
Vaccine; 2007 Dec; 25(52):8807-32. PubMed ID: 18037545
[TBL] [Abstract][Full Text] [Related]
9. Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox.
Pittman PR; Hahn M; Lee HS; Koca C; Samy N; Schmidt D; Hornung J; Weidenthaler H; Heery CR; Meyer TPH; Silbernagl G; Maclennan J; Chaplin P
N Engl J Med; 2019 Nov; 381(20):1897-1908. PubMed ID: 31722150
[TBL] [Abstract][Full Text] [Related]
10. ACAM2000 clonal Vero cell culture vaccinia virus (New York City Board of Health strain)--a second-generation smallpox vaccine for biological defense.
Monath TP; Caldwell JR; Mundt W; Fusco J; Johnson CS; Buller M; Liu J; Gardner B; Downing G; Blum PS; Kemp T; Nichols R; Weltzin R
Int J Infect Dis; 2004 Oct; 8 Suppl 2():S31-44. PubMed ID: 15491873
[TBL] [Abstract][Full Text] [Related]
11. Use of Vaccinia Virus Smallpox Vaccine in Laboratory and Health Care Personnel at Risk for Occupational Exposure to Orthopoxviruses - Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2015.
Petersen BW; Harms TJ; Reynolds MG; Harrison LH
MMWR Morb Mortal Wkly Rep; 2016 Mar; 65(10):257-62. PubMed ID: 26985679
[TBL] [Abstract][Full Text] [Related]
12. Development of smallpox vaccine candidates with integrated interleukin-15 that demonstrate superior immunogenicity, efficacy, and safety in mice.
Perera LP; Waldmann TA; Mosca JD; Baldwin N; Berzofsky JA; Oh S
J Virol; 2007 Aug; 81(16):8774-83. PubMed ID: 17553867
[TBL] [Abstract][Full Text] [Related]
13. Enhanced safety surveillance study of ACAM2000 smallpox vaccine among US military service members.
Decker MD; Garman PM; Hughes H; Yacovone MA; Collins LC; Fegley CD; Lin G; DiPietro G; Gordon DM
Vaccine; 2021 Sep; 39(39):5541-5547. PubMed ID: 34454787
[TBL] [Abstract][Full Text] [Related]
14. Recent advances in the study of live attenuated cell-cultured smallpox vaccine LC16m8.
Eto A; Saito T; Yokote H; Kurane I; Kanatani Y
Vaccine; 2015 Nov; 33(45):6106-11. PubMed ID: 26319072
[TBL] [Abstract][Full Text] [Related]
15. Ischemic cardiac events and other adverse events following ACAM2000(®) smallpox vaccine in the Vaccine Adverse Event Reporting System.
McNeil MM; Cano M; R Miller E; Petersen BW; Engler RJ; Bryant-Genevier MG
Vaccine; 2014 Aug; 32(37):4758-65. PubMed ID: 24951868
[TBL] [Abstract][Full Text] [Related]
16. Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults.
Kennedy JS; Gurwith M; Dekker CL; Frey SE; Edwards KM; Kenner J; Lock M; Empig C; Morikawa S; Saijo M; Yokote H; Karem K; Damon I; Perlroth M; Greenberg RN
J Infect Dis; 2011 Nov; 204(9):1395-402. PubMed ID: 21921208
[TBL] [Abstract][Full Text] [Related]
17. Smallpox vaccine safety is dependent on T cells and not B cells.
Gordon SN; Cecchinato V; Andresen V; Heraud JM; Hryniewicz A; Parks RW; Venzon D; Chung HK; Karpova T; McNally J; Silvera P; Reimann KA; Matsui H; Kanehara T; Shinmura Y; Yokote H; Franchini G
J Infect Dis; 2011 Apr; 203(8):1043-53. PubMed ID: 21450994
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the safety and immunogenicity of ACAM1000, ACAM2000 and Dryvax in healthy vaccinia-naive adults.
Frey SE; Newman FK; Kennedy JS; Ennis F; Abate G; Hoft DF; Monath TP
Vaccine; 2009 Mar; 27(10):1637-44. PubMed ID: 19071184
[TBL] [Abstract][Full Text] [Related]
19. Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.
Meseda CA; Garcia AD; Kumar A; Mayer AE; Manischewitz J; King LR; Golding H; Merchlinsky M; Weir JP
Virology; 2005 Sep; 339(2):164-75. PubMed ID: 15993917
[TBL] [Abstract][Full Text] [Related]
20. Co-administration of tecovirimat and ACAM2000™ in non-human primates: Effect of tecovirimat treatment on ACAM2000 immunogenicity and efficacy versus lethal monkeypox virus challenge.
Russo AT; Berhanu A; Bigger CB; Prigge J; Silvera PM; Grosenbach DW; Hruby D
Vaccine; 2020 Jan; 38(3):644-654. PubMed ID: 31677948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
